641 Monotherapy with tadalafil or tamsulosin for moderate-to-severe lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): Results from an international, double-blind, placebo-controlled trial

Lower Urinary Tract ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Double Blind ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial

Arab Journal of Urology ◽

10.1016/j.aju.2016.11.001 ◽

2017 ◽

Vol 15 (1) ◽

pp. 53-59 ◽

Cited By ~ 10

Author(s):

Amr Fawzi ◽

Mostafa Kamel ◽

Emad Salem ◽

Esam Desoky ◽

Mohamed Omran ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Double Blind ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

1245 EFFECTS OF TADALAFIL OR TAMSULOSIN ON LOWER URINARY TRACT SYMPTOMS SUGGESTIVE OF BENIGN PROSTATIC HYPERPLASIA AND ON ERECTILE DYSFUNCTION: RESULTS FROM AN INTERNATIONAL, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

The Journal of Urology ◽

10.1016/j.juro.2012.02.1563 ◽

2012 ◽

Vol 187 (4S) ◽

Cited By ~ 1

Author(s):

Matthias Oelke ◽

Francois Giuliano ◽

Vicenzo Mirone ◽

Lei Xu ◽

David Cox ◽

...

Keyword(s):

Erectile Dysfunction ◽

Urinary Tract ◽

Lower Urinary Tract ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Double Blind ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Tadalafil 5 mg once-daily therapy for men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a randomized, double-blind, placebo-controlled trial carried out in Japan and Korea

International Journal of Urology ◽

10.1111/iju.12410 ◽

2014 ◽

Vol 21 (7) ◽

pp. 670-675 ◽

Cited By ~ 29

Author(s):

Masayuki Takeda ◽

Osamu Yokoyama ◽

Sung Won Lee ◽

Masahiro Murakami ◽

Yoji Morisaki ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Faculty Opinions recommendation of A multicenter, randomized, double-blind, placebo controlled study of onabotulinumtoxinA 200 U to treat lower urinary tract symptoms in men with benign prostatic hyperplasia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718270633.793512123 ◽

2015 ◽

Author(s):

Peter Gilling

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of OnabotulinumtoxinA 200 U to Treat Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia

The Journal of Urology ◽

10.1016/j.juro.2014.02.004 ◽

2014 ◽

Vol 192 (1) ◽

pp. 150-156 ◽

Cited By ~ 27

Author(s):

Kevin T. McVary ◽

Claus G. Roehrborn ◽

Emmanuel Chartier-Kastler ◽

Mitchell Efros ◽

Denise Bugarin ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Editorial Comment to Tadalafil 5 mg once-daily therapy for men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a randomized, double-blind, placebo-controlled trial carried out in Japan and Korea

International Journal of Urology ◽

10.1111/iju.12422 ◽

2014 ◽

Vol 21 (7) ◽

pp. 676-676

Author(s):

Hironobu Akino

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Efficacy and Safety of Tadalafil Once Daily in the Treatment of Men With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Results of an International Randomized, Double-Blind, Placebo-Controlled Trial

European Urology ◽

10.1016/j.eururo.2011.08.005 ◽

2011 ◽

Vol 60 (5) ◽

pp. 1105-1113 ◽

Cited By ~ 119

Author(s):

Hartmut Porst ◽

Edward D. Kim ◽

Adolfo R. Casabé ◽

Vincenzo Mirone ◽

Roberta J. Secrest ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms

Urology ◽

10.1016/s0090-4295(01)01442-x ◽

2001 ◽

Vol 58 (6) ◽

pp. 960-963 ◽

Cited By ~ 61

Author(s):

Glenn S Gerber ◽

Dimitri Kuznetsov ◽

Bernard C Johnson ◽

Jay D Burstein

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Controlled Trial ◽

Double Blind ◽

Saw Palmetto ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Reply to Stephen Shei-Dei Yang and Shang-Jen Chang's Letter to the Editor re: Christopher R. Chapple, Francesco Montorsi, Teuvo L.J. Tammela, et al. Silodosin Therapy for Lower Urinary Tract Symptoms in Men with Suspected Benign Prostatic Hyperplasia: Results of an International, Randomized, Double-Blind, Placebo- and Active-Controlled Clinical Trial Performed in Europe. Eur Urol 2011;59:342–52

European Urology ◽

10.1016/j.eururo.2011.04.037 ◽

2011 ◽

Vol 60 (2) ◽

pp. e12-e13

Author(s):

Christopher R. Chapple

Keyword(s):

Clinical Trial ◽

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Double-blind randomized placebo-controlled study of bixa orellana in patients with lower urinary tract symptoms associated to benign prostatic hyperplasia

International braz j urol ◽

10.1590/s1677-55382007000400006 ◽

2007 ◽

Vol 33 (4) ◽

pp. 493-501 ◽

Cited By ~ 11

Author(s):

Luis Zegarra ◽

Abraham Vaisberg ◽

Cesar Loza ◽

Roxana L. Aguirre ◽

Miguel Campos ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Bixa Orellana ◽

Double Blind ◽

Urinary Tract Symptoms ◽